Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-012454

Director sold 69,401 shares at $6.10 ($423,506)

From the SEC's structured data for this filing

Trades in this filing

LAWLOR AUGUSTINE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-02-25 Sale : show line 1 in the form −69,401 $6.10 $423,506 0 I
Open-market sales · 69,401 sh · avg $6.10 · $423,506
Loading xslF345X03/doc4.xml…